Early treatment reliably prevents long-haul COVID symptoms (PACS)

 Early COVID-19 therapy with azithromycin plus nitazoxanide, ivermectin or hydroxychloroquine in outpatient settings significantly improved outcomes compared to known outcomes in untreated patients.

• If you got treated early, there was no long-haul.

Will the medical community advise patients to do this?

• It's very unlikely because all early treatments were demonized by the NIH and CDC in order to allow for EUAs to be granted to the vaccine makers.
• So they keep that information from public view and recommend Paxlovid instead (which is not 95% effective and doesn't reduce your rate of long-haul COVID).

Look what the medical community did to Paul Marik

• They fired him for using effective treatments
• The key is to treat people early with repurposed drugs
• In April 2020, shortly after the pandemic started, Marik started the COVID-19 Early Treatment Fund
• No world government was spending any money funding the testing of these early treatment protocols
• He put in $1M of his own money and raised another $5M from mostly private donors

https://stevekirsch.substack.com/p/early-treatment-reliably-prevents?utm_source=post-email-title&publication_id=548354&post_id=81105685&isFreemail=true&utm_medium=email